VACCINATIONS AND THE RISK OF RELAPSE IN MULTIPLE SCLEROSIS
暂无分享,去创建一个
Amy | Ourdès | Ukusic | S. Andra | ATRICIA | AMY | Andra | alérie | UISSA | ADDIER | ALÉRIE | OURDÈS | ANDRA | UKUSIC | Atricia | G. Roup | S. Tudy | Uissa | Addier | C. Hristian | C. Onfavreux | Amy S Uissa | P. Atricia | S. Addier | V. Alérie | B. Ourdès | V. Ukusic | V. Accines | In M Ultiple | S. Clerosis | G. Roup
[1] M. Maclure. The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.
[2] R. Tukkie,et al. Bilateral optic neuritis with branch retinal artery occlusion associated with vaccination , 2005, Documenta Ophthalmologica.
[3] P. Adeleine,et al. Risk of cancer from azathioprine therapy in multiple sclerosis , 1996, Neurology.
[4] W. Sibley,et al. Swine influenza vaccination in patients with multiple sclerosis. , 1978, Archives of neurology.
[5] R. Riikonen. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children , 1989, Acta neurologica Scandinavica.
[6] M. Yahr,et al. Relapsing encephalomyelitis following the use of influenza vaccine. , 1972, Archives of neurology.
[7] M. Hutchinson,et al. Rate of Pregnancy-Related Relapse in Multiple Sclerosis , 1998 .
[8] P. Duclos. Adverse events after hepatitis B vaccination. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[9] J. Keyser,et al. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine , 1991, The Lancet.
[10] S. Ellenberg,et al. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. , 1996, The Pediatric Infectious Disease Journal.
[11] L. Davis,et al. Immune status of patients with multiple sclerosis , 1972, Neurology.
[12] G. Aimard,et al. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.
[13] F. Mérei,et al. The possible role of vaccines and sera in the pathogenesis of multiple sclerosis. , 1961, World neurology.
[14] A. Flanders,et al. MR imaging in a case of postvaccination myelitis. , 1995, AJNR. American journal of neuroradiology.
[15] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[16] C. Pozzilli,et al. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination , 1995, Journal of Neurology.
[17] F. Retornaz,et al. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[18] R. Knobler,et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis , 1997, Neurology.
[19] W. Linssen,et al. Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. , 2000, Neurology.
[20] J. Keyser,et al. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis , 1998, Journal of the Neurological Sciences.
[21] H. Miller,et al. Multiple sclerosis and vaccination. , 1967, British medical journal.
[22] S. Hadler,et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. , 1988, American journal of epidemiology.
[23] C Confavreux,et al. EDMUS, a European database for multiple sclerosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[24] F. Zipp,et al. No increase in demyelinating diseases after hepatitis B vaccination , 1999, Nature Medicine.
[25] L. Kurland,et al. Swine flu vaccine and multiple sclerosis. , 1984, JAMA.
[26] W. Sibley,et al. INFECTION AND IMMUNIZATION IN MULTIPLE SCLEROSIS * , 1965, Annals of the New York Academy of Sciences.
[27] A. Sadovnick,et al. School-based hepatitis B vaccination programme and adolescent multiple sclerosis , 2000, The Lancet.
[28] B. McMahon,et al. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. , 1992, The American journal of medicine.
[29] O. Eeg‐Olofsson,et al. A PROSPECTIVE STUDY of PARAPARESES IN WESTERN SWEDEN , 1976, Acta neurologica Scandinavica.
[30] J. Nadler. Multiple sclerosis and hepatitis B vaccination. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] F. Trevisani,et al. Transverse myelitis following hepatitis B vaccination. , 1993, Journal of hepatology.
[32] O. Zwisler,et al. Vaccination of patients with encephalomyelitis disseminata. , 1991, Vaccine.
[33] G. Ellison,et al. Swine influenza virus vaccination in patients with multiple sclerosis. , 1977, The Journal of infectious diseases.
[34] Lublin Fd,et al. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .
[35] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[36] G. Marchal,et al. Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. , 1990, European Neurology.
[37] W. Sibley,et al. Influenza vaccination in patients with multiple sclerosis. , 1976, JAMA.